2 results
Approved WMOCompleted
To investigate if infarct size can be limited by introduction of IABP prior to intervention.
Approved WMOWill not start
ObjectivesPrimary* To determine the efficacy (as assessed by radiographic progression free survival [rPFS]) of AZD4635 plus durvalumab and separately of AZD4635 plus durvalumab plus cabazitaxel in participants with mCRPC.Secondary* To evaluate theā¦